Objective: The first (primacy region) and last (recency region) items of a word list are generally better memorized than items from the middle region. The recency effect depends on short-term memory (STM) and the primacy effect on long-term memory (LTM), where verbal information is transferred from STM into LTM by maintenance rehearsal. We compared the serial position effects (SPE) between patients with mild cognitive impairment (MCI) due to Parkinson’s disease (PD), i.e., PD-MCI, and patients with MCI due to Alzheimer’s disease (AD-MCI), and evaluated the influence of SPE and frontostriatal deficits on verbal memory recall. Methods: Four similar groups of subjects participated in the study: 26 PD-MCI patients, 26 cognitively normal patients with PD (PD-CN), 26 AD-MCI patients, and 26 normal controls (NC). Verbal episodic memory, verbal span, attentional capacity, executive functions, and verbal working memory performance were assessed. Measures for primacy and recency regions were defined at the first trial of a 16-items word list. Hierarchical regression models were used to investigate the contribution of frontostriatal deficits beyond SPE on verbal memory recall performance (“long-delay free recall”) in PD and AD patients. Results: Primacy effects were significantly diminished in both PD-MCI and AD-MCI patients relative to NC and PD-CN (all p < 0.01). Compared to PD-MCI patients, AD-MCI patients exhibited significantly worse “delayed-recall ‘savings’.” Reduced primacy effect was predictive for decreased recall performance in PD and AD. The conducted hierarchical regression model revealed that in PD, but not in AD patients, performance of attention and executive function significantly increased the prediction of free recalled words. Conclusions: Reduced recall performance is likely due to impaired transition of newly learned material from STM into LTM in AD and in PD. Whereas AD-MCI patients suffer from a storage deficit, the similarly reduced recall performance found in patients with PD-MCI may additionally be related to deficient attentional and executive capacity.

1.
Aarsland
D
,
Brønnick
K
,
Larsen
JP
,
Tysnes
OB
,
Alves
G
;
Norwegian ParkWest Study Group
.
Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study
.
Neurology
.
2009
Mar
;
72
(
13
):
1121
6
.
[PubMed]
0028-3878
2.
Aarsland
D
,
Bronnick
K
,
Williams-Gray
C
,
Weintraub
D
,
Marder
K
,
Kulisevsky
J
, et al
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis
.
Neurology
.
2010
Sep
;
75
(
12
):
1062
9
.
[PubMed]
0028-3878
3.
Mayes
AR
,
Roberts
N
.
Theories of episodic memory
.
Philos Trans R Soc Lond B Biol Sci
.
2001
Sep
;
356
(
1413
):
1395
408
.
[PubMed]
0962-8436
4.
Zgaljardic
DJ
,
Borod
JC
,
Foldi
NS
,
Mattis
P
.
A review of the cognitive and behavioral sequelae of Parkinson’s disease: relationship to frontostriatal circuitry
.
Cogn Behav Neurol
.
2003
Dec
;
16
(
4
):
193
210
.
[PubMed]
1543-3633
5.
Weintraub
D
,
Moberg
PJ
,
Culbertson
WC
,
Duda
JE
,
Stern
MB
.
Evidence for impaired encoding and retrieval memory profiles in Parkinson disease
.
Cogn Behav Neurol
.
2004
Dec
;
17
(
4
):
195
200
.
[PubMed]
1543-3633
6.
Brønnick
K
,
Alves
G
,
Aarsland
D
,
Tysnes
OB
,
Larsen
JP
.
Verbal memory in drug-naive, newly diagnosed Parkinson’s disease. The retrieval deficit hypothesis revisited
.
Neuropsychology
.
2011
Jan
;
25
(
1
):
114
24
.
[PubMed]
0894-4105
7.
Chiaravalloti
ND
,
Ibarretxe-Bilbao
N
,
DeLuca
J
,
Rusu
O
,
Pena
J
,
García-Gorostiaga
I
, et al
The source of the memory impairment in Parkinson’s disease: acquisition versus retrieval
.
Mov Disord
.
2014
May
;
29
(
6
):
765
71
.
[PubMed]
0885-3185
8.
McKhann
GM
,
Knopman
DS
,
Chertkow
H
,
Hyman
BT
,
Jack
CR
 Jr
,
Kawas
CH
, et al
The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
.
Alzheimers Dement
.
2011
May
;
7
(
3
):
263
9
.
[PubMed]
1552-5260
9.
Foldi
NS
,
Brickman
AM
,
Schaefer
LA
,
Knutelska
ME
.
Distinct serial position profiles and neuropsychological measures differentiate late life depression from normal aging and Alzheimer’s disease
.
Psychiatry Res
.
2003
Aug
;
120
(
1
):
71
84
.
[PubMed]
0165-1781
10.
Cunha
C
,
Guerreiro
M
,
de Mendonça
A
,
Oliveira
PE
,
Santana
I
.
Serial position effects in Alzheimer’s disease, mild cognitive impairment, and normal aging: predictive value for conversion to dementia
.
J Clin Exp Neuropsychol
.
2012
;
34
(
8
):
841
52
.
[PubMed]
1380-3395
11.
Moser
B
,
Deisenhammer
EA
,
Marksteiner
J
,
Papousek
I
,
Fink
A
,
Weiss
EM
.
Serial position effects in patients with mild cognitive impairment and early and moderate Alzheimer’s disease compared with healthy comparison subjects
.
Dement Geriatr Cogn Disord
.
2014
;
37
(
1-2
):
19
26
.
[PubMed]
1420-8008
12.
Egli
SC
,
Beck
IR
,
Berres
M
,
Foldi
NS
,
Monsch
AU
,
Sollberger
M
.
Serial position effects are sensitive predictors of conversion from MCI to Alzheimer’s disease dementia
.
Alzheimers Dement
.
2014
Oct
;
10
(
5
Suppl
):
S420
4
.
[PubMed]
1552-5260
13.
Taylor
AE
,
Saint-Cyr
JA
,
Lang
AE
.
Frontal lobe dysfunction in Parkinson’s disease. The cortical focus of neostriatal outflow
.
Brain
.
1986
Oct
;
109
(
Pt 5
):
845
83
.
[PubMed]
0006-8950
14.
Stefanova
ED
,
Kostic
VS
,
Ziropadja
LJ
,
Ocic
GG
,
Markovic
M
.
Declarative memory in early Parkinson’s disease: serial position learning effects
.
J Clin Exp Neuropsychol
.
2001
Oct
;
23
(
5
):
581
91
.
[PubMed]
1380-3395
15.
Gibb
WR
,
Lees
AJ
.
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease
.
J Neurol Neurosurg Psychiatry
.
1988
Jun
;
51
(
6
):
745
52
.
[PubMed]
0022-3050
16.
Folstein
MF
,
Folstein
SE
,
McHugh
PR
.
“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician
.
J Psychiatr Res
.
1975
Nov
;
12
(
3
):
189
98
.
[PubMed]
0022-3956
17.
Litvan
I
,
Goldman
JG
,
Tröster
AI
,
Schmand
BA
,
Weintraub
D
,
Petersen
RC
, et al
Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines
.
Mov Disord
.
2012
Mar
;
27
(
3
):
349
56
.
[PubMed]
0885-3185
18.
Albert
MS
,
DeKosky
ST
,
Dickson
D
,
Dubois
B
,
Feldman
HH
,
Fox
NC
, et al
The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
.
Alzheimers Dement
.
2011
May
;
7
(
3
):
270
9
.
[PubMed]
1552-5260
19.
Delis
D
,
Kramer
J
,
Ober
B
,
Kaplan
E
.
The California Verbal Learning Test: Administration and interpretation
.
San Antonio (TX)
:
Psychological Corporation
;
1987
.
20.
Stricker
JL
,
Brown
GG
,
Wixted
J
,
Baldo
JV
,
Delis
DC
.
New semantic and serial clustering indices for the California Verbal Learning Test-Second Edition: background, rationale, and formulae
.
J Int Neuropsychol Soc
.
2002
Mar
;
8
(
3
):
425
35
.
[PubMed]
1355-6177
21.
Zimmermann
P
,
Fimm
B.
Testbatterie zur Aufmerksamkeitsprüfung.
Herzogenrath: Psytest Psychologische Testsysteme;
2007
.
22.
Reitan
RM
.
VALIDITY OF THE TRAIL MAKING TEST AS AN INDICATOR OF ORGANIC BRAIN DAMAGE
.
Percept Mot Skills
.
1958
Dec
;
8
(
3
):
271
6
. 0031-5125
23.
Thurstone
LL
.
Primary mental abilities
.
Science
.
1948
Nov
;
108
(
2813
):
585
.
[PubMed]
0036-8075
24.
Isaacs
B
,
Kennie
AT
.
The Set test as an aid to the detection of dementia in old people
.
Br J Psychiatry
.
1973
Oct
;
123
(
575
):
467
70
.
[PubMed]
0007-1250
25.
Härtig
C
,
Markowitsch
HJ
,
Neufeld
H
,
Calabrese
P
,
Deisinger
K
,
Kessler
J
. Wechsler Gedächtnis Test - Revisierte Fassung.
2000
26.
Fahn
S
,
Elton
R
. Unified Parkinsons Disease Rating Scale. In:
Fahn
S
,
Marsden
CD
,
Goldstein
M
,
Calne
DB
, editors
.
Recent developments in Parkinson’s disease
.
Florham Park (NJ)
:
Macmillan Healthcare Information
;
1987
. pp.
153
63
.
27.
Tomlinson
CL
,
Stowe
R
,
Patel
S
,
Rick
C
,
Gray
R
,
Clarke
CE
.
Systematic review of levodopa dose equivalency reporting in Parkinson’s disease
.
Mov Disord
.
2010
Nov
;
25
(
15
):
2649
53
.
[PubMed]
0885-3185
28.
R Core Team
. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing;
2012
.Available from: http://www.R-project.org/
29.
Mahurin
R
,
Feher
E
,
Nance
M
,
Levy
J
,
Pirozzolo
F
.
Cognition in Parkinson’s disease and related disorders. Neuropsychology of Alzheimer’s Disease and Related Disorders
.
New York
:
Oxford University Press
;
1993
.
30.
Lezak
MD
.
Neuropsychological Assessment
.
Oxford University Press
;
2004
.
31.
Atkinson
RC
,
Shiffrin
RM
. Human Memory: A Proposed System and its Control Processes11This research was supported by the National Aeronautics and Space Administration, Grant No. NGR-05-020-036. The authors are indebted to W. K. Estes and G. H. Bower who provided many valuable suggestions and comments at various stages of the work. Special credit is due J. W. Brelsford who was instrumental in carrying out the research discussed in Section IV and whose overall contributions are too numerous to report in detail. We should also like to thank those co-workers who carried out a number of the experiments discussed in the latter half of the paper; rather than list them here, each will be acknowledged at the appropriate place. In: Spence KW, Spence JT, editors. Psychology of Learning and Motivation. Academic Press;
1968
; pp 89–195.
32.
Berlyand
Y
,
Weintraub
D
,
Xie
SX
,
Mellis
IA
,
Doshi
J
,
Rick
J
, et al
An Alzheimer’s Disease-Derived Biomarker Signature Identifies Parkinson’s Disease Patients with Dementia
.
PLoS One
.
2016
Jan
;
11
(
1
):
e0147319
.
[PubMed]
1932-6203
33.
Weintraub
D
,
Dietz
N
,
Duda
JE
,
Wolk
DA
,
Doshi
J
,
Xie
SX
, et al
Alzheimer’s disease pattern of brain atrophy predicts cognitive decline in Parkinson’s disease
.
Brain
.
2012
Jan
;
135
(
Pt 1
):
170
80
.
[PubMed]
0006-8950
34.
Irwin
DJ
,
Lee
VM
,
Trojanowski
JQ
.
Parkinson’s disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
.
Nat Rev Neurosci
.
2013
Sep
;
14
(
9
):
626
36
.
[PubMed]
1471-003X
35.
Marra
C
,
Ferraccioli
M
,
Vita
MG
,
Quaranta
D
,
Gainotti
G
.
Patterns of cognitive decline and rates of conversion to dementia in patients with degenerative and vascular forms of MCI
.
Curr Alzheimer Res
.
2011
Feb
;
8
(
1
):
24
31
.
[PubMed]
1567-2050
36.
Duncan
GW
,
Firbank
MJ
,
O’Brien
JT
,
Burn
DJ
.
Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson’s disease?
Mov Disord
.
2013
Apr
;
28
(
4
):
425
38
.
[PubMed]
0885-3185
37.
Beyer
MK
,
Bronnick
KS
,
Hwang
KS
,
Bergsland
N
,
Tysnes
OB
,
Larsen
JP
, et al
Verbal memory is associated with structural hippocampal changes in newly diagnosed Parkinson’s disease
.
J Neurol Neurosurg Psychiatry
.
2013
Jan
;
84
(
1
):
23
8
.
[PubMed]
0022-3050
38.
Pauls
F
,
Petermann
F
,
Lepach
AC
.
Gender differences in episodic memory and visual working memory including the effects of age
.
Memory
.
2013
;
21
(
7
):
857
74
.
[PubMed]
0965-8211
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.